http://www.xconomy.com/san-diego/2009/09/09/vivus-rival-to-arena-and-orexigen-nails-big-results-in-clinical-trials-of-obesity-drug/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 12:29:49 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/san-diego/2009/09/09/vivus-rival-to-arena-and-orexigen-nails-big-results-in-clinical-trials-of-obesity-drug/comment-page-1/#comment-80684 Gloria Johnson Wed, 09 Sep 2009 13:08:47 +0000 http://www.xconomy.com/?p=40750#comment-80684 Another excellent article Luke, completely balanced coverage of the obesity drug Qnexa. I must admit VVUS had unbelievably great weight loss results from their clinical trials. If they truly have a clean safety profile as well, Qnexa will be a huge multi billion dollar winner. Now let's see what Arena's lorcaserin can do . . . Another excellent article Luke, completely balanced coverage of the obesity drug Qnexa. I must admit VVUS had unbelievably great weight loss results from their clinical trials. If they truly have a clean safety profile as well, Qnexa will be a huge multi billion dollar winner. Now let’s see what Arena’s lorcaserin can do . . .

]]>